Sociedad Española de Farmacia Hospitalaria

What Sociedad Española de Farmacia Hospitalaria does

Sociedad Española de Farmacia Hospitalaria (SEFH) is a private, nonprofit scientific professional society founded in 1955 and headquartered in Madrid, Spain, dedicated to advancing hospital pharmacy practice and the safe, appropriate use of medicines. Its primary constituents are Spain's hospital pharmacists — specialists, FIR residents, and pharmacy technicians — whom it serves through a unified educational platform (formaSEFH) comprising four role-specific sub-platforms (DPC for continuing professional development, R-FARMA for residents, EXPERT for advanced specialists, and TECHNIFARM for technicians), alongside the Medline-indexed scientific journal Farmacia Hospitalaria and the annual National Congress (currently the 71st edition, scheduled for October 2026 in Gran Canaria).

SEFH's core strategic product is the MAPEX initiative (Mapa Estratégico de Atención Farmacéutica al Paciente Externo), launched in 2014, which bundles the CMO (Capacity-Motivation-Opportunity) pharmaceutical care model, patient stratification tools for multiple therapeutic areas, a telepharmacy framework with validated indicator dashboards, and the Q-PEX quality certification standard — the first-in-class certification framework for outpatient pharmacy units in Spain, under which 20+ hospitals have been certified or re-certified. The CMOs model has documented adaptations for oncology, hematology, cardiovascular, pediatric, HIV, VHC, inflammatory diseases, and multiple sclerosis patients.

SEFH generates revenue from membership dues, congress and event registration fees, journal subscriptions, and project sponsorship from 16+ pharmaceutical companies (including AbbVie, Roche, Novartis, Pfizer, and others). It operates as a recognized partner of Spain's AEMPS regulator, the European Commission, and industry associations (Farmaindustria, AESEG), and is governed by a member-elected Junta de Gobierno under its Strategic Plan 2023-2027. SEFH is a registered nonprofit association (CIF G-78259041) with an affiliated foundation, the Fundación Española de Farmacia Hospitalaria (FEFH), which manages grants, awards, and educational scholarships.

Name

Sociedad Española de Farmacia Hospitalaria

Legal name

Sociedad Española de Farmacia Hospitalaria

Website

https://sefh.es

Company type

Private

Founded year

1955

Operating status

Operating

Headcount range

11–50 employees

Short description

Sociedad Española de Farmacia Hospitalaria (SEFH) is a Spanish nonprofit scientific society founded in 1955 that serves hospital pharmacists through education, certification, and the MAPEX outpatient pharmaceutical care initiative.

Ownership category

akta.pro rank

Product category

Healthcare Professional Association Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Health Services (8000)

akta.pro primary industry

Training & Competency Programs for GxP Compliance (HLAGAKAM)

akta.pro secondary industries

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Hospital pharmacy services
• Pharmaceutical care
• Clinical pharmacy practice
• Professional certification programs
• Medical education

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Membership Dues: SEFH operates as a membership-based professional society. Hospital pharmacists and related professionals pay membership fees to access member-only resources, the members area, certificate downloads, SEFH mailing list, and training platforms.
2. Congress and Event Fees: The organization organizes the annual national SEFH congress (71st Congress in October 2026 in Gran Canaria), as well as workshops, conferences, and webinars. These events generate revenue through registration fees and sponsor participation.
3. Journal and Publications: SEFH publishes the scientific journal 'Farmacia Hospitalaria' (Volume 50, current issue May-June 2026) and other monographs and publications, generating revenue through subscriptions and publication access.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Core offering

SEFH is a Spanish nonprofit scientific professional society that advances the practice of hospital pharmacy through professional development programs, a peer-reviewed scientific journal, an annual national congress, and a pioneering quality certification program for outpatient pharmacy units. It operates the formaSEFH educational platform (aggregating DPC, R-FARMA, EXPERT, and TECHNIFARM sub-platforms) and runs the MAPEX strategic initiative for outpatient pharmaceutical care, including the CMO pharmaceutical care model, Q-PEX certification, telepharmacy frameworks, and patient stratification tools. The society serves as the national reference body for hospital pharmacists and hospital pharmacy departments across Spain.

Product overview

SEFH (Sociedad Española de Farmacia Hospitalaria) is a non-profit scientific professional society for hospital pharmacists in Spain. Its product portfolio centres on the formaSEFH educational platform — comprising four sub-platforms (DPC for specialists, R-FARMA for residents, EXPERT for advanced practitioners, and TECHNIFARM for technicians) — and the MAPEX strategic initiative for outpatient pharmaceutical care transformation, which includes the CMO care model, patient stratification tools, the telepharmacy framework, and the Q-PEX quality certification standard. Additional offerings encompass the Farmacia Hospitalaria journal, the annual SEFH National Congress, a virtual library, quality indicator observatories, and various digital resources including apps and software tools.

Differentiator

Problem solved

Functional benefit

Products and services

• formaSEFH Educational Platform A unified online educational platform aggregating all SEFH training activities for hospital pharmacists, residents, expert practitioners, and pharmacy technicians. It hosts active and archived courses, competency mapping, and officially accredited programmes across four sub-platforms (DPC for specialists, R-FARMA for residents, EXPERT for advanced practitioners, and TECHNIFARM for technicians).
• MAPEX Strategic Initiative for Outpatient Pharmaceutical Care Strategic initiative launched in 2014 by SEFH to transform pharmaceutical care for outpatients through a CMO (Capacity–Motivation–Opportunity) model, care stratification tools, telepharmacy frameworks, quality certification (Q-PEX), and a network of regional ambassadors across Spain. It integrates assisted, teaching, and research dimensions with hospital pharmacists as key transformation leaders.
• Q-PEX Quality Certification Standard A pioneering quality certification standard for outpatient pharmaceutical care units (UPEFH) aligned with excellence and quality standards, with three to four certification levels (Basic, Intermediate, Medium, Advanced) and a certification tool enabling hospitals to assess and improve their care quality. Over 20 hospitals in Spain are certified or re-certified.
• SEFH National Congress Annual national scientific congress for hospital pharmacists (currently the 71st Congress scheduled for Gran Canaria, October 2026), with abstracts books, e-poster platforms, and scientific sessions going back to the 59th Congress. Major annual professional gathering with industry sponsors and healthcare professional engagement.
• Farmacia Hospitalaria Scientific Journal Peer-reviewed scientific journal indexed in Medline, providing authoritative research in hospital pharmacy. Currently at Volume 50 (2026), it serves as a primary scientific publication outlet for hospital pharmacy research in Spain.

Quantifiable outcome

• Over 20 hospitals certified under Q-PEX quality standard for outpatient pharmacy units
• +2 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

20 partnerships are on record, tiered core and minor.

• AEMPS (Spanish Agency of Medicines and Medical Devices)coreStrategic or Co-development Partner · 1 January 2022AEMPS collaborated with SEFH, Farmaindustria, and AESEG on the digital medication information pilot launched in 2022 in coordination with the European Commission. The initiative replaces paper prospectuses with online access through the CIMA database for 656 hospital-only drugs.
• FarmaindustriacoreStrategic or Co-development Partner · 1 January 2022Farmaindustria partnered with SEFH, AEMPS, and AESEG on the digital medication information pilot to eliminate paper prospectuses for hospital-only medications, providing access through the CIMA database.
• AESEG (Spanish Association of Generic Medicines)coreStrategic or Co-development Partner · 1 January 2022AESEG partnered with SEFH, AEMPS, and Farmaindustria on the digital medication information pilot for hospital-only drugs, replacing paper prospectuses with online CIMA database access.
• AbbVieminorOthersAbbVie is a sponsor of the MAPEX project, contributing to the strategic initiative for pharmaceutical care to external patients led by SEFH.
• AstellasminorOthersAstellas is a sponsor of the MAPEX project, contributing to the strategic initiative for pharmaceutical care to external patients led by SEFH.
• BiogenminorOthersBiogen is a sponsor of the MAPEX project, contributing to the strategic initiative for pharmaceutical care to external patients led by SEFH.
• Bristol Myers Squibb (BMS)minorOthersBMS is a sponsor of the MAPEX project, contributing to the strategic initiative for pharmaceutical care to external patients led by SEFH.
• JanssenminorOthersJanssen is a sponsor of the MAPEX project, contributing to the strategic initiative for pharmaceutical care to external patients led by SEFH.
• Leo PharmaminorOthersLeo Pharma is a sponsor of the MAPEX project, contributing to the strategic initiative for pharmaceutical care to external patients led by SEFH.
• Eli LillyminorOthersEli Lilly is a sponsor of the MAPEX project, contributing to the strategic initiative for pharmaceutical care to external patients led by SEFH.
• MSDminorOthersMSD is a sponsor of the MAPEX project, contributing to the strategic initiative for pharmaceutical care to external patients led by SEFH.
• NovartisminorOthersNovartis is a sponsor of the MAPEX project, contributing to the strategic initiative for pharmaceutical care to external patients led by SEFH.
• RocheminorOthersRoche is a sponsor of the MAPEX project, contributing to the strategic initiative for pharmaceutical care to external patients led by SEFH.
• MerckminorOthersMerck is a sponsor of the MAPEX project, contributing to the strategic initiative for pharmaceutical care to external patients led by SEFH.
• SanofiminorOthersSanofi is a sponsor of the MAPEX project, contributing to the strategic initiative for pharmaceutical care to external patients led by SEFH.
• AmgenminorOthersAmgen is a collaborator of the MAPEX project, contributing as a project supporter alongside other pharmaceutical companies.
• Boehringer IngelheimminorOthersBoehringer Ingelheim is a collaborator of the MAPEX project, contributing as a project supporter alongside other pharmaceutical companies.
• GileadminorOthersGilead is a collaborator of the MAPEX project, contributing as a project supporter alongside other pharmaceutical companies.
• European CommissioncoreStrategic or Co-development PartnerThe European Commission coordinated the digital medication information pilot in Spain, of which SEFH is a key partner alongside AEMPS, Farmaindustria, and AESEG. The initiative is expected to serve as a model for future EU pharmaceutical legislation.
• PfizerminorOthersPfizer is a sponsor of the telepharmacy resources within the MAPEX project, supporting the development of telepharmacy guidelines and methodological support tools.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• International Pharmaceutical Federation (FIP): Global umbrella federation of national pharmaceutical associations including hospital pharmacy. SEFH operates within FIP's Hospital Pharmacy Section; useful as the parent federation peer for international policy work and global standards.
• Royal Pharmaceutical Society (RPS): The UK professional body for pharmacists covering all settings (community, hospital, industry). Comparable in chartered status, credentialing, and CPD frameworks; broader scope than SEFH but overlaps on hospital pharmacy Faculty and education portfolio.

Direct peers

• American Society of Health-System Pharmacists (ASHP): The US national professional society for hospital pharmacists, with analogous functions: accredited continuing education, specialty certification, practice standards, and policy advocacy. Directly comparable mission, scale, and member-driven governance model.
• Canadian Society of Hospital Pharmacists (CSHP): Canada's national society for hospital pharmacists, providing accredited education, specialty recognition, and practice standards. Comparable governance model and revenue mix (membership, events, sponsorships).
• Society of Hospital Pharmacists of Australia (SHPA): Australia's national professional organization for hospital pharmacists with similar CPD, specialty practice frameworks, and Medicines Information / clinical pharmacy standards — comparable scale and member services portfolio.
• European Association of Hospital Pharmacists (EAHP): The pan-European umbrella society for hospital pharmacists covering 35+ country member associations including SEFH itself. Comparable scope of educational programs, policy statements, and the common training framework for hospital pharmacy specialization.
• Bundesverband Deutscher Krankenhausapotheker (ADKA): The German federal association of hospital pharmacists. Comparable national membership society with continuing education, certification, and advocacy functions; useful reference for adjacent EU market dynamics.
• Società Italiana di Farmacia Ospedaliera (SIFO): Italy's national scientific society of hospital pharmacists. Closely comparable in mission, training program structure, congress operations, and regulatory engagement with national medicines agencies — direct southern-European peer.
• Société Française de Pharmacie Clinique (SFPC): French national society for clinical pharmacy; closely comparable training, certification, and clinical-pharmacy methodology focus, with analogous relationships to French medicines agency and hospital networks.

Others

• Fundación Española de Farmacia Hospitalaria (FEFH): SEFH's jointly controlled nonprofit foundation, providing scholarships, prizes, and research grants. Highly relevant adjacent entity sharing staff, governance, and mission; useful as a structural / funding peer rather than a market competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/sefh_
• YouTubeyoutube.com/user/SEFHVIDEOS
• Facebookfacebook.com/SefhFarmaciaHospitalaria
• LinkedInlinkedin.com/company/sociedad-espanola-de-farmacia-hospitalaria-sefh
• Instagraminstagram.com/sefh_farmaciahospitalaria
• TikToktiktok.com/@sefh_farmaciahospital

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sociedad Española de Farmacia Hospitalaria